US 6576793
&bgr;2-adrenergic receptor agonists
expired A61KA61K31/137A61K31/167
Quick answer
US patent 6576793 (&bgr;2-adrenergic receptor agonists) held by Theravance, Inc. expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/137, A61K31/167, A61K31/403, A61K31/404